Lysogeny and bacteriophage host range within the Burkholderia cepacia complex

Journal of Medical Microbiology

Volumn 52, Issue 6, 2003, Pages 483-490

  Langley, Ross ^a   Kenna, Dervla T ^a   Vandamme, Peter ^b   Ure, Rebecca ^a   Govan, John R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; EVOLUTION; GRANULOMATOSIS; HOST RANGE; IMMUNE DEFICIENCY; LYSOGENIZATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIOPHAGES; BURKHOLDERIA CEPACIA; HUMANS; LYSOGENY; MICROSCOPY, ELECTRON; PLANTS; SOIL MICROBIOLOGY;

EID: 0038772023     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05099-0     Document Type: Article

References (49)

1. Agodi, A., Mahenthiralingam, E., Barchitta, M., Gianninò, V., Sciacca, A. & Stefani, S. (2001). Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 39, 2891-2896.
2. Allison, G. E. & Verma, N. K. (2000). Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends Microbiol 8, 17-23.
3. Aris, R. M., Routh, J. C., LiPuma, J. J., Heath, D. G. & Gilligan, P. H. (2001). Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 164, 2102-2106.
4. Berriatua, E., Ziluaga, I., Miguel-Virto, C., Uribarren, P., Juste, R., Laevens, S., Vandamme, P. & Govan, J. R. W. (2001). Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol 39, 990-994.
5. Bevivino, A., Dalmastri, C., Tabacchioni, S., Chiarini, L., Belli, M. L., Piana, S., Materazzo, A., Vandamme, P. & Manno, G. (2002). Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 40, 846-851.
6. Butler, S. L., Doherty, C. J., Hughes, J. E., Nelson, J. W. & Govan, J. R. W. (1995). Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol 33, 1001-1004.
7. Cihlar, R. L., Lessie, T. G. & Holt, S. C. (1978). Characterization of bacteriophage CP1, an organic solvent sensitive phage associated with Pseudomonas cepacia. Can J Microbiol 24, 1404-1412.
8. Coenye, T., Vandamme, P., Govan, J. R. W. & LiPuma, J. J. (2001). Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39, 3427-3436.
9. Environmental Protection Agency (2002). Burkholderia cepacia complex: proposed significant new use rule. Fed Regist 67, 1179-1186.
10. Fisher, M. C., LiPuma, J. J., Dasen, S. E., Caputo, G. C., Mortensen, J. E., McGowan, K. L. & Stull, T. L. (1993). Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J Pediatr 123, 745-747.
11. Govan, J. R. W. & Harris, G. (1985). Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol 22, 490-494.
12. Govan, J. R. W. & Vandamme, P. (1998). Agricultural and medical microbiology: a time for bridging gaps. Microbiology 144, 2373-2375.
13. Govan, J. R. W., Hughes, J. E. & Vandamme, P. (1996). Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 45, 395-407.
14. Govan, J. R. W., Balandreau, J. & Vandamme, P. (2000). Burkholderia cepacia - friend and foe. ASM News 66, 124-125.
15. Gutmann, L., Agarwal, M., Arthur, M., Campanelli, C. & Goldstein, R. (1990). A phasmid shuttle vector for the cloning of complex operons in Salmonella. Plasmid 23, 42-58.
16. Hancock, R. E. W. (1997). Peptide antibiotics. Lancet 349, 418-422.
17. Holloway, B. W., Egan, J. B. & Monk, M. (1960). Lysogeny in Pseudomonas aeruginosa. Aust J Exp Biol Med Sci 38, 321-329.
18. Holmes, A., Govan, J. & Goldstein, R. (1998). Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 4, 221-227.
19. Holmes, A., Nolan, R., Taylor, R., Finley, R., Riley, M., Jiang, R.-Z., Steinbach, S. & Goldstein, R. (1999). An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 179, 1197-1205.
20. Hughes, J. E, Stewart, J., Barclay, G. R. & Govan, J. R. W. (1997). Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 65, 4281-4287.
21. Jones, A. M., Dodd, M. E. & Webb, A. K. (2001). Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 17, 295-301.
22. Kenna, D. T., Barcus, V. A., Langley, R. J., Vandamme, P. & Govan, J. R. W. (2003). Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex. FEMS Immunol Med Microbiol 35, 87-92.
23. Lessie, T. G., Hendrickson, W., Manning, B. D. & Devereux, R. (1996). Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol Lett 144, 117-128.
24. Lewin, C., Doherty, C. & Govan, J. (1993). In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, cotrimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother 37, 123-125.
25. LiPuma, J. J. (1998). Burkholderia cepacia. Management issues and new insights. Clin Chest Med 19, 473-486.
26. LiPuma, J. J. & Mahenthiralingam, E. (1999). Commercial use of Burkholderia cepacia. Emerg Infect Dis 5, 305-306.
27. LiPuma, J. J., Mahenthiralingam, E., Mark, G. L. & Gonzalez, C. F. (2000). Isolation of soil-borne genomovar III Burkholderia cepacia and lytic phages with interspecies host range. Pediatr Pulmonol S20, 288-289 (abstract).
28. LiPuma, J. J., Spilker, T., Gill, L. H., Campbell, P. W., III, Liu, L. & Mahenthiralingam, E. (2001). Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164, 92-96.
29. Mack, K. & Titball, R. W. (1998). The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia. FEMS Microbiol Lett 162, 69-74.
30. Mahenthiralingam, E., Coenye, T., Chung, J. W., Speert, D. P., Govan, J. R. W., Taylor, P. & Vandamme, P. (2000a). Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38, 910-913.
31. Mahenthiralingam, E., Bischof, J., Byrne, S. K., Radomski, C., Davies, J. E., Av-Gay, Y. & Vandamme, P. (2000b). DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38, 3165-3173.
32. Mahenthiralingam, E., Baldwin, A. & Vandamme, P. (2002). Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 51, 533-538.
33. Matsumoto, H., Itoh, Y., Ohta, S. & Terawaki, Y. (1986). A generalized transducing phage of Pseudomonas cepacia. J Gen Microbiol 132, 2583-2586.
34. Nzula, S., Vandamme, P. & Govan, J. R. W. (2000). Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages. FEMS Immunol Med Microbiol 28, 307-312.
35. Nzula, S., Vandamme, P. & Govan, J. R. W. (2002). Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 50, 265-269.
36. Parke, J. L. & Gurian-Sherman, D. (2001). Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu Rev Phytopathol 39, 225-258.
37. Pirisi, A. (2000). Phage therapy - advantages over antibiotics? Lancet 356, 1418.
38. Pitt, T. L., Kaufmann, M. E., Patel, P. S., Benge, L. C. A., Gaskin, S. & Livermore, D. M. (1996). Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 44, 203-210.
39. Schuch, R., Nelson, D. & Fischetti, V. A. (2002). A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889.
40. Schulin, T. & Steinmetz, I. (2001). Chronic melioidosis in a patient with cystic fibrosis. J Clin Microbiol 39, 1676-1677.
41. Shaw, D., Poxton, I. R. & Govan, J. R. W. (1995). Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol 11, 99-106.
42. Speert, D. P., Henry, D.,Vandamme, P., Corey, M. & Mahenthiralingam, E. (2002). Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 8, 181-187.
43. Sulakvelidze, A., Alavidze, Z. & Morris, J. G., Jr (2001). Bacteriophage therapy. Antimicrob Agents Chemother 45, 649-659.
44. Vandamme, P., Holmes, B., Vancanneyt, M. & 8 other authors (1997). Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 47, 1188-1200.
45. Vandamme, P., Holmes, B., Coenye, T., Goris, J., Mahenthiralingam, E., LiPuma, J. J. & Govan, J. R. W. (2003). Burkholderia cenocepacia sp. nov. - a new twist to an old story. Res Microbiol 154, 91-96.
46. Vermis, K., Vandekerckhove, C., Nelis, H. J. & Vandamme, P. A. R. (2002). Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex. FEMS Microbiol Lett 214, 1-5.
47. Visca, P., Cazzola, G., Petrucca, A. & Braggion, C. (2001). Travel-associated Burkholderia pseudomallei infection (melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 32, E15-E16.
48. Weiss, B. D., Capage, M. A., Kessel, M. & Benson, S. A. (1994). Isolation and characterization of a generalized transducing phage for Xanthomonas campestris pv. campestris. J Bacteriol 176, 3354-3359.
49. Wigley, P. & Burton, N. F. (2000). Multiple chromosomes in Burkholderia cepacia and B. gladioli and their distribution in clinical and environmental strains of B. cepacia. J Appl Microbiol 88, 914-918.